An Indian-American cardiologist and entrepreneur has invested $60mn in a medical company that will support clinical trial on cardiac devices to replace the stent.
Dr. Kiran Patel's investment is for the Concept Medical Inc, a Florida-based medical device company's Investigational Device Exemption (IDE) for world's first sirolimus-coated balloon.
Reportedly, Patel's investment will pave way for clinical studies to reduce the risk of heart blockages.
Sirolimus balloon catheter is a drug-coated balloon- a replacement of the stent.
If a stent cannot be placed in a human body, then sirolimus balloon is used.
Patel's investment will pay for clinical studies on cardiac devices coated with a substance that reduces the risk of heart blockages and the length of time a patient needs to take blood thinners, Concept Medical Inc said.
Noting that cardiovascular diseases represent 31% of all global deaths, Patel said that his contribution will help towards healthcare of millions of people worldwide.
"I'm excited to be a part of CMI whose research & innovative technologies will meet a major unmet need in patients with... cardiovascular diseases. This venture enables me to contribute to millions of hearts beating around the world," Patel said.
Love World news?
Subscribe to stay updated.